← Open Payments lookup

KAMALVEER GREWAL: Open Payments

NPI 1902301203 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$671 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $147 · 2025 $671

Food & beverage: $671
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.2$227
Axsome Therapeutics, Inc.1$125
ABBVIE INC.1$115
Supernus Pharmaceuticals, Inc.1$103
Neurocrine BioSciences, Inc.1$101

Products named: AUSTEDO XR, Auvelity, VRAYLAR, Qelbree, INGREZZA.

Industry payments across NY — which companies pay providers there.